Neos Investment Management LLC Arcus Biosciences, Inc. Transaction History
Neos Investment Management LLC
- $2.43 Trillion
- Q2 2024
A detailed history of Neos Investment Management LLC transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 34,606 shares of RCUS stock, worth $576,535. This represents 0.02% of its overall portfolio holdings.
Number of Shares
34,606
Previous 11,477
201.52%
Holding current value
$576,535
Previous $217 Million
143.23%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding RCUS
# of Institutions
207Shares Held
48.9MCall Options Held
173KPut Options Held
151K-
Black Rock Inc. New York, NY9.76MShares$163 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$87.6 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA4.25MShares$70.7 Million0.65% of portfolio
-
State Street Corp Boston, MA3.06MShares$50.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.83MShares$30.6 Million0.08% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $1.2B
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...